Defining the research agenda to measure and reduce tuberculosis stigmas

K. MacIntyre, M. I. Bakker, S. Bergson, R. Bhavaraju, V. Bond, J. Chikovore, C. Colvin, G. M. Craig, A. L. Cremers, A. Daftary, N. Engel, N. Ferris France, E. Jaramillo, M. Kimerling, A. Kipp, S. Krishnaratne, C. Mergenthaler, M. Ngicho, L. Redwood, E. J.J. Rood & 7 others N. Sommerland, A. Stangl, A. Van Rie, W. Van Brakel, E. Wouters, A. Zwerling, E. M.H. Mitchell

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Crucial to finding and treating the 4 million tuberculosis (TB) patients currently missed by national TB programmes, TB stigma is receiving well-deserved and longdelayed attention at the global level. However, the ability to measure and evaluate the success of TB stigmareduction efforts is limited by the need for additional tools. At a 2016 TB stigma-measurement meeting held in The Hague, The Netherlands, stigma experts discussed and proposed a research agenda around four themes: 1) drivers: what are the main drivers and domains of TB stigma(s)?; 2) consequences: how consequential are TB stigmas and how are negative impacts most felt?; 3) burden: what is the global prevalence and distribution of TB stigma(s) and what explains any variation? 4): intervention: what can be done to reduce the extent and impact of TB stigma(s)? Each theme was further subdivided into research topics to be addressed to move the agenda forward. These include greater clarity on what causes TB stigmas to emerge and thrive, the difficulty of measuring the complexity of stigma, and the improbability of a universal stigma 'cure'. Nevertheless, these challenges should not hinder investments in the measurement and reduction of TB stigma.We believe it is time to focus on how, and not whether, the global community should measure and reduce TB stigma.

LanguageEnglish
PagesS87-S96
JournalInternational Journal of Tuberculosis and Lung Disease
Volume21
DOIs
Publication statusPublished - 1 Nov 2017

Cite this

MacIntyre, K., Bakker, M. I., Bergson, S., Bhavaraju, R., Bond, V., Chikovore, J., ... Mitchell, E. M. H. (2017). Defining the research agenda to measure and reduce tuberculosis stigmas. International Journal of Tuberculosis and Lung Disease, 21, S87-S96. https://doi.org/10.5588/ijtld.17.0151
MacIntyre, K. ; Bakker, M. I. ; Bergson, S. ; Bhavaraju, R. ; Bond, V. ; Chikovore, J. ; Colvin, C. ; Craig, G. M. ; Cremers, A. L. ; Daftary, A. ; Engel, N. ; France, N. Ferris ; Jaramillo, E. ; Kimerling, M. ; Kipp, A. ; Krishnaratne, S. ; Mergenthaler, C. ; Ngicho, M. ; Redwood, L. ; Rood, E. J.J. ; Sommerland, N. ; Stangl, A. ; Van Rie, A. ; Van Brakel, W. ; Wouters, E. ; Zwerling, A. ; Mitchell, E. M.H. / Defining the research agenda to measure and reduce tuberculosis stigmas. In: International Journal of Tuberculosis and Lung Disease. 2017 ; Vol. 21. pp. S87-S96.
@article{06ace2f67e10454d842e971cf24566e9,
title = "Defining the research agenda to measure and reduce tuberculosis stigmas",
abstract = "Crucial to finding and treating the 4 million tuberculosis (TB) patients currently missed by national TB programmes, TB stigma is receiving well-deserved and longdelayed attention at the global level. However, the ability to measure and evaluate the success of TB stigmareduction efforts is limited by the need for additional tools. At a 2016 TB stigma-measurement meeting held in The Hague, The Netherlands, stigma experts discussed and proposed a research agenda around four themes: 1) drivers: what are the main drivers and domains of TB stigma(s)?; 2) consequences: how consequential are TB stigmas and how are negative impacts most felt?; 3) burden: what is the global prevalence and distribution of TB stigma(s) and what explains any variation? 4): intervention: what can be done to reduce the extent and impact of TB stigma(s)? Each theme was further subdivided into research topics to be addressed to move the agenda forward. These include greater clarity on what causes TB stigmas to emerge and thrive, the difficulty of measuring the complexity of stigma, and the improbability of a universal stigma 'cure'. Nevertheless, these challenges should not hinder investments in the measurement and reduction of TB stigma.We believe it is time to focus on how, and not whether, the global community should measure and reduce TB stigma.",
keywords = "Discrimination, Equity, Human rights, Respect, Social justice",
author = "K. MacIntyre and Bakker, {M. I.} and S. Bergson and R. Bhavaraju and V. Bond and J. Chikovore and C. Colvin and Craig, {G. M.} and Cremers, {A. L.} and A. Daftary and N. Engel and France, {N. Ferris} and E. Jaramillo and M. Kimerling and A. Kipp and S. Krishnaratne and C. Mergenthaler and M. Ngicho and L. Redwood and Rood, {E. J.J.} and N. Sommerland and A. Stangl and {Van Rie}, A. and {Van Brakel}, W. and E. Wouters and A. Zwerling and Mitchell, {E. M.H.}",
year = "2017",
month = "11",
day = "1",
doi = "10.5588/ijtld.17.0151",
language = "English",
volume = "21",
pages = "S87--S96",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union Against Tuberculosis and Lung Disease (The Union)",

}

MacIntyre, K, Bakker, MI, Bergson, S, Bhavaraju, R, Bond, V, Chikovore, J, Colvin, C, Craig, GM, Cremers, AL, Daftary, A, Engel, N, France, NF, Jaramillo, E, Kimerling, M, Kipp, A, Krishnaratne, S, Mergenthaler, C, Ngicho, M, Redwood, L, Rood, EJJ, Sommerland, N, Stangl, A, Van Rie, A, Van Brakel, W, Wouters, E, Zwerling, A & Mitchell, EMH 2017, 'Defining the research agenda to measure and reduce tuberculosis stigmas', International Journal of Tuberculosis and Lung Disease, vol. 21, pp. S87-S96. https://doi.org/10.5588/ijtld.17.0151

Defining the research agenda to measure and reduce tuberculosis stigmas. / MacIntyre, K.; Bakker, M. I.; Bergson, S.; Bhavaraju, R.; Bond, V.; Chikovore, J.; Colvin, C.; Craig, G. M.; Cremers, A. L.; Daftary, A.; Engel, N.; France, N. Ferris; Jaramillo, E.; Kimerling, M.; Kipp, A.; Krishnaratne, S.; Mergenthaler, C.; Ngicho, M.; Redwood, L.; Rood, E. J.J.; Sommerland, N.; Stangl, A.; Van Rie, A.; Van Brakel, W.; Wouters, E.; Zwerling, A.; Mitchell, E. M.H.

In: International Journal of Tuberculosis and Lung Disease, Vol. 21, 01.11.2017, p. S87-S96.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Defining the research agenda to measure and reduce tuberculosis stigmas

AU - MacIntyre, K.

AU - Bakker, M. I.

AU - Bergson, S.

AU - Bhavaraju, R.

AU - Bond, V.

AU - Chikovore, J.

AU - Colvin, C.

AU - Craig, G. M.

AU - Cremers, A. L.

AU - Daftary, A.

AU - Engel, N.

AU - France, N. Ferris

AU - Jaramillo, E.

AU - Kimerling, M.

AU - Kipp, A.

AU - Krishnaratne, S.

AU - Mergenthaler, C.

AU - Ngicho, M.

AU - Redwood, L.

AU - Rood, E. J.J.

AU - Sommerland, N.

AU - Stangl, A.

AU - Van Rie, A.

AU - Van Brakel, W.

AU - Wouters, E.

AU - Zwerling, A.

AU - Mitchell, E. M.H.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Crucial to finding and treating the 4 million tuberculosis (TB) patients currently missed by national TB programmes, TB stigma is receiving well-deserved and longdelayed attention at the global level. However, the ability to measure and evaluate the success of TB stigmareduction efforts is limited by the need for additional tools. At a 2016 TB stigma-measurement meeting held in The Hague, The Netherlands, stigma experts discussed and proposed a research agenda around four themes: 1) drivers: what are the main drivers and domains of TB stigma(s)?; 2) consequences: how consequential are TB stigmas and how are negative impacts most felt?; 3) burden: what is the global prevalence and distribution of TB stigma(s) and what explains any variation? 4): intervention: what can be done to reduce the extent and impact of TB stigma(s)? Each theme was further subdivided into research topics to be addressed to move the agenda forward. These include greater clarity on what causes TB stigmas to emerge and thrive, the difficulty of measuring the complexity of stigma, and the improbability of a universal stigma 'cure'. Nevertheless, these challenges should not hinder investments in the measurement and reduction of TB stigma.We believe it is time to focus on how, and not whether, the global community should measure and reduce TB stigma.

AB - Crucial to finding and treating the 4 million tuberculosis (TB) patients currently missed by national TB programmes, TB stigma is receiving well-deserved and longdelayed attention at the global level. However, the ability to measure and evaluate the success of TB stigmareduction efforts is limited by the need for additional tools. At a 2016 TB stigma-measurement meeting held in The Hague, The Netherlands, stigma experts discussed and proposed a research agenda around four themes: 1) drivers: what are the main drivers and domains of TB stigma(s)?; 2) consequences: how consequential are TB stigmas and how are negative impacts most felt?; 3) burden: what is the global prevalence and distribution of TB stigma(s) and what explains any variation? 4): intervention: what can be done to reduce the extent and impact of TB stigma(s)? Each theme was further subdivided into research topics to be addressed to move the agenda forward. These include greater clarity on what causes TB stigmas to emerge and thrive, the difficulty of measuring the complexity of stigma, and the improbability of a universal stigma 'cure'. Nevertheless, these challenges should not hinder investments in the measurement and reduction of TB stigma.We believe it is time to focus on how, and not whether, the global community should measure and reduce TB stigma.

KW - Discrimination

KW - Equity

KW - Human rights

KW - Respect

KW - Social justice

UR - http://www.scopus.com/inward/record.url?scp=85032004831&partnerID=8YFLogxK

U2 - 10.5588/ijtld.17.0151

DO - 10.5588/ijtld.17.0151

M3 - Article

VL - 21

SP - S87-S96

JO - International Journal of Tuberculosis and Lung Disease

T2 - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

ER -